Fortress Biotech, Inc. (NASDAQ:FBIO) said its majority-owned subsidiary Cyprium Therapeutics has signed a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for gross ...

CNBC's Julia Boorstin joins 'Fast Money' to highlight the 2026 Changemakers list.

At first glance, the European Commission’s Biotech Act proposal may appear as another sectoral initiative aimed at boosting innovation. On closer reading, however, it signals something far more ...

As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...

The news hit the biotech industry like a bucket of cold water: the White House's proposed plan to significantly cut funding from the National Institutes of Health (NIH). As the primary U.S. agency ...

Health-care companies fell as traders fled high-risk niches such as biotechnology and obesity-drug makers. Eli Lilly shares slipped after it agreed to acquire Verve Therapeutics for about $1 billion ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Cosmos Health Inc. ('Cosmos Health' or the 'Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its ...

AI search is fundamentally changing how consumers navigate decision making, and brands must adapt in order to be discoverable.

The Potential for Biotechnology to Address Forest Health will focus on trees and consider the use of biotechnology to prevent the extirpation of a single tree species by an insect or disease that ...

Suggested Citation: "7 Moving Ahead." National Academies of Sciences, Engineering, and Medicine. 2019. Forest Health and Biotechnology: Possibilities and ...